{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:43:17Z","timestamp":1790908997546,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007938","name":"Qingdao University of Science and Technology","doi-asserted-by":"publisher","award":["ZR2020MH055"],"award-info":[{"award-number":["ZR2020MH055"]}],"id":[{"id":"10.13039\/501100007938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.abb.2022.109269","type":"journal-article","created":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T09:37:07Z","timestamp":1651397827000},"page":"109269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1"],"prefix":"10.1016","volume":"725","author":[{"given":"Hongzeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangrong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5660-6261","authenticated-orcid":false,"given":"Yanling","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib1","first-page":"207","article-title":"Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic","volume":"25","author":"Mouzaki","year":"2012","journal-title":"Ann. Gastroenterol."},{"issue":"11","key":"10.1016\/j.abb.2022.109269_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.4254\/wjh.v7.i11.1450","article-title":"Non-alcoholic fatty liver disease in 2015","volume":"7","author":"Ahmed","year":"2015","journal-title":"World J. Hepatol."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.abb.2022.109269_bib4","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.abb.2022.109269_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC","volume":"76","author":"Yip","year":"2022","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.abb.2022.109269_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib8","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/hep.28584","article-title":"Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Lonardo","year":"2016","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.abb.2022.109269_bib9","doi-asserted-by":"crossref","first-page":"ITC65","DOI":"10.7326\/AITC201811060","article-title":"Nonalcoholic fatty liver disease","volume":"169","author":"Wang","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/mc.20601","article-title":"Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis","volume":"49","author":"Kaur","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.abb.2022.109269_bib11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lfs.2018.11.031","article-title":"Modulation of inducible nitric oxide synthase pathway by eugenol and telmisartan in carbon tetrachloride-induced liver injury in rats","volume":"216","author":"Fathy","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.abb.2022.109269_bib12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lfs.2018.11.034","article-title":"Eugenol ameliorates insulin resistance, oxidative stress and inflammation in high fat-diet\/streptozotocin-induced diabetic rat","volume":"216","author":"Al-Trad","year":"2019","journal-title":"Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.abb.2022.109269_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11010-013-1824-2","article-title":"Ameliorating effect of eugenol on hyperglycemia by attenuating the key enzymes of glucose metabolism in streptozotocin-induced diabetic rats","volume":"385","author":"Srinivasan","year":"2014","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.abb.2022.109269_bib14","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005344-200402000-00013","article-title":"Cardiovascular effects of eugenol, a phenolic compound present in many plant essential oils, in normotensive rats","volume":"43","author":"Lahlou","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.tox.2009.12.018","article-title":"Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats","volume":"268","author":"Yogalakshmi","year":"2010","journal-title":"Toxicology"},{"issue":"8","key":"10.1016\/j.abb.2022.109269_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1248\/bpb.b14-00281","article-title":"Eugenol ameliorates hepatic steatosis and fibrosis by down-regulating SREBP1 gene expression via AMPK-mTOR-p70S6K signaling pathway","volume":"37","author":"Jo","year":"2014","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.abb.2022.109269_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218543","article-title":"Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice","volume":"14","author":"Zhao","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/nu12010094","article-title":"Intestinal fructose and glucose metabolism in health and disease","volume":"12","author":"Merino","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cmet.2004.12.004","article-title":"The hypothalamic arcuate nucleus: a key site for mediating leptin's effects on glucose homeostasis and locomotor activity","volume":"1","author":"Coppari","year":"2005","journal-title":"Cell Metabol."},{"issue":"12","key":"10.1016\/j.abb.2022.109269_bib20","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/nm1202-798","article-title":"Hypothalamic insulin signaling is required for inhibition of glucose production","volume":"8","author":"Obici","year":"2002","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib21","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/pr.115.011395","article-title":"Glucagon-like peptide-1 and its class B G protein-coupled receptors: a long march to therapeutic successes","volume":"68","author":"Graaf","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"5","key":"10.1016\/j.abb.2022.109269_bib22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nm.3787","article-title":"Metformin activates a duodenal Ampk-dependent pathway to lower hepatic glucose production in rats","volume":"21","author":"Duca","year":"2015","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.abb.2022.109269_bib23","doi-asserted-by":"crossref","first-page":"G762","DOI":"10.1152\/ajpgi.00476.2011","article-title":"Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice","volume":"302","author":"Trevaskis","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/hepr.12551","article-title":"Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress-associated pathway","volume":"46","author":"Ao","year":"2016","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11154-014-9288-6","article-title":"Gut microbiota and GLP-1","volume":"15","author":"Everard","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib26","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00394-017-1524-x","article-title":"Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis","volume":"57","author":"de Faria Ghetti","year":"2018","journal-title":"Eur. J. Nutr."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/1469-0691.12140","article-title":"Gut microbiota and non-alcoholic fatty liver disease: new insights","volume":"19","author":"Aron-Wisnewsky","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.abb.2022.109269_bib28","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1038\/srep09253","article-title":"Phytonutrient diet supplementation promotes beneficial Clostridia species and intestinal mucus secretion resulting in protection against enteric infection","volume":"5","author":"Wlodarska","year":"2015","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.clinre.2016.07.005","article-title":"Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases","volume":"41","author":"Motamed","year":"2017","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib30","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ecl.2016.06.005","article-title":"Nonalcoholic fatty liver disease: the new complication of type 2 diabetes mellitus","volume":"45","author":"Bril","year":"2016","journal-title":"Endocrinol Metab. Clin. N. Am."},{"issue":"8","key":"10.1016\/j.abb.2022.109269_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.abb.2022.109269_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4274\/tjps.62207","article-title":"Pharmacological and toxicological properties of eugenol","volume":"14","author":"Mohammadi Nejad","year":"2017","journal-title":"Turk. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib33","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/1547691X.2013.832444","article-title":"Differential effects of eugenol against hepatic inflammation and overall damage induced by ischemia\/re-perfusion injury","volume":"11","author":"Abd El Motteleb","year":"2014","journal-title":"J. Immunot."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib34","doi-asserted-by":"crossref","first-page":"14003","DOI":"10.1038\/s41598-019-50352-4","article-title":"Eugenol reduces LDL cholesterol and hepatic steatosis in hypercholesterolemic rats by modulating TRPV1 receptor","volume":"9","author":"Harb","year":"2019","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib35","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2016.07.003","article-title":"Nonalcoholic fatty liver disease: pathophysiology and management","volume":"45","author":"Carr","year":"2016","journal-title":"Gastroenterol. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib36","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/hep.22478","article-title":"The gut-brain-liver axis: a new option to treat obesity and diabetes?","volume":"48","author":"Beraza","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.abb.2022.109269_bib37","doi-asserted-by":"crossref","first-page":"824305","DOI":"10.1155\/2012\/824305","article-title":"Obesity and appetite control","volume":"2012","author":"Suzuki","year":"2012","journal-title":"Exp. Diabetes Res."},{"issue":"12","key":"10.1016\/j.abb.2022.109269_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrgastro.2012.185","article-title":"Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis","volume":"9","author":"Dong","year":"2012","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.abb.2022.109269_bib39","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fendo.2019.00260","article-title":"From the incretin concept and the discovery of GLP-1 to today's diabetes therapy","volume":"10","author":"Holst","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/nyas.14211","article-title":"Incretins in obesity and diabetes","volume":"1461","author":"Chia","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.abb.2022.109269_bib41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/oby.21107","article-title":"GLP-1 receptor agonists: nonglycemic clinical effects in weight loss and beyond","volume":"23","author":"Ryan","year":"2015","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib42","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.pneurobio.2010.07.003","article-title":"Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides","volume":"92","author":"Vrang","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.abb.2022.109269_bib43","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/emm.2016.4","article-title":"Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism","volume":"48","author":"Roh","year":"2016","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib44","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00429-020-02189-1","article-title":"Distribution and ultrastructural localization of the glucagon-like peptide-1 receptor (GLP-1R) in the rat brain","volume":"226","author":"Farkas","year":"2021","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.abb.2022.109269_bib45","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnins.2015.00092","article-title":"GLP-1 based therapeutics: simultaneously combating T2DM and obesity","volume":"9","author":"Heppner","year":"2015","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib46","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jss.2014.03.062","article-title":"Impact of the hepatic branch of the vagus and Roux-en-Y gastric bypass on the hypoglycemic effect and glucagon-like peptide-1 in rats with type 2 diabetes mellitus","volume":"191","author":"Qiu","year":"2014","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib47","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1038\/s41598-017-05371-4","article-title":"Glucagon-like peptide-1 reduces pancreatic beta-cell mass through hypothalamic neural pathways in high-fat diet-induced obese rats","volume":"7","author":"Ando","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.abb.2022.109269_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/bib\/bbz157","article-title":"Machine learning approaches and databases for prediction of drug-target interaction: a survey paper","volume":"22","author":"Bagherian","year":"2021","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.abb.2022.109269_bib49","doi-asserted-by":"crossref","first-page":"680117","DOI":"10.3389\/fgene.2021.680117","article-title":"Application of machine learning for drug-target interaction prediction","volume":"12","author":"Xu","year":"2021","journal-title":"Front. Genet."},{"issue":"2","key":"10.1016\/j.abb.2022.109269_bib50","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/gut.48.2.206","article-title":"The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis","volume":"48","author":"Wigg","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.abb.2022.109269_bib51","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1073\/pnas.1000080107","article-title":"Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample","volume":"108","author":"Caporaso","year":"2011","journal-title":"P Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.abb.2022.109269_bib52","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1039\/C7FO01528C","article-title":"Gut : liver : brain axis: the microbial challenge in the hepatic encephalopathy","volume":"9","author":"Mancini","year":"2018","journal-title":"Food Funct."},{"issue":"4","key":"10.1016\/j.abb.2022.109269_bib53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1152\/physiol.00041.2015","article-title":"Linking gut microbiota and inflammation to obesity and insulin resistance","volume":"31","author":"Saad","year":"2016","journal-title":"Physiology"},{"issue":"5","key":"10.1016\/j.abb.2022.109269_bib54","doi-asserted-by":"crossref","first-page":"G659","DOI":"10.1152\/ajpgi.00079.2018","article-title":"Mesenteric adipose tissue contributes to intestinal barrier integrity and protects against nonalcoholic fatty liver disease in mice","volume":"315","author":"Wu","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"2","key":"10.1016\/j.abb.2022.109269_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00024382-199908000-00006","article-title":"Effect of mesenteric ischemia and reperfusion or hemorrhagic shock on intestinal mucosal permeability and ATP content in rats","volume":"12","author":"Wattanasirichaigoon","year":"1999","journal-title":"Shock"}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:22:04Z","timestamp":1757744524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986122001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":55,"alternative-id":["S0003986122001539"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2022.109269","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eugenol alleviated nonalcoholic fatty liver disease in rat via a gut-brain-liver axis involving glucagon-like Peptide-1","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2022.109269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109269"}}